These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study]. Sinnassamy P; Andre JL; Treize G; Leroy B Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412 [TBL] [Abstract][Full Text] [Related]
3. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin. Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853 [TBL] [Abstract][Full Text] [Related]
4. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801 [TBL] [Abstract][Full Text] [Related]
5. [Recombinant human erythropoietin (rh-EPO) in chronic, dialysis-dependent renal failure: effects on macro- and microcirculation and hematologic parameters]. Köhler M; Mörsdorf S; Jung F; Braun B; Waldhausen P; Pindur G; Weber U; Bosslet R; Bambauer R; Jutzler GA Beitr Infusionsther; 1990; 26():89-95. PubMed ID: 1703909 [TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of recombinant human erythropoietin in the treatment of transfusion-dependent anemia in patients on chronic dialysis]. Graf H; Mayer G; Cada EM; Thum J; Stummvoll HK Wien Klin Wochenschr; 1987 Dec; 99(24):855-9. PubMed ID: 3439185 [TBL] [Abstract][Full Text] [Related]
8. [Improvement of hemorheologic parameters in hemodialyzed patients treated with human recombinant erythropoietin]. Delamaire M; Durand F; Hamel D; Joyeux V; Lepogamp P; Genetet B J Mal Vasc; 1991; 16(3):289-94. PubMed ID: 1940657 [TBL] [Abstract][Full Text] [Related]
9. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients. Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889 [TBL] [Abstract][Full Text] [Related]
10. [Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis]. Pietrzyk JA; Smolnik T; Szymowska M; Dyras P; Lenik J Przegl Lek; 1992; 49(1-2):55-60. PubMed ID: 1455008 [TBL] [Abstract][Full Text] [Related]
11. The effect of patient size and dose of recombinant human erythropoietin therapy on red blood cell volume expansion in autologous blood donors for elective orthopedic operation. Goodnough LT; Verbrugge D; Marcus RE; Goldberg V J Am Coll Surg; 1994 Aug; 179(2):171-6. PubMed ID: 8044386 [TBL] [Abstract][Full Text] [Related]
12. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241 [TBL] [Abstract][Full Text] [Related]
13. [Erythropoietin--the first hematologic hormone in clinical use]. Rhyner K Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin]. Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartůnková J; Válek A Cas Lek Cesk; 1989 Sep; 128(40):1257-60. PubMed ID: 2582471 [TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Attallah N; Osman-Malik Y; Frinak S; Besarab A Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte 5'-nucleotidase and aminopeptidase N activity in patients on maintenance hemodialysis treated with human recombinant erythropoietin and 1-alpha-D3. Stefanovic V; Mitić-Zlatkovic M; Radivojevic J; Vlahovic P Ren Fail; 2005; 27(3):283-8. PubMed ID: 15957544 [TBL] [Abstract][Full Text] [Related]
17. Effect of erythropoietin treatment on tissue oxygenation in patients with severe transfusion dependent renal anaemia. Landgraf H; Grützmacher P; Garcia-Bartels C; Bergmann M; Ehrly AM; Schoeppe W Eur J Med; 1993; 2(7):393-7. PubMed ID: 8258026 [TBL] [Abstract][Full Text] [Related]
18. Hemoglobin and 2,3-diphosphoglycerate levels in transfused dialysis patients with myocardial infarction. Crowley JP; Valeri CR; Metzger JB; Pono L; Chazan J Ann Clin Lab Sci; 1992; 22(1):11-7. PubMed ID: 1739269 [TBL] [Abstract][Full Text] [Related]
19. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Chen YC; Hung SC; Tarng DC Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299 [TBL] [Abstract][Full Text] [Related]
20. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis. Acharya VN; Sinha DK; Almeida AF; Pathare AV J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]